Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.

Nel mirino della Casa Bianca le Big Pharma che non hanno rispettato l’impegno a costruire un nuovo stabilimento negli Stati Uniti

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.